12 Key Signs of Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease (CMT) is a group of inherited neurological disorders that affect the peripheral nerves, which are responsible for carrying signals between the brain, spinal cord, and muscles. Because these nerves play an important role in movement, balance, and sensation, changes in their function can gradually lead to noticeable symptoms. Although CMT is considered a rare condition, recognizing its early signs can help individuals seek medical advice, receive appropriate support, and better understand the progression of the disease.

The symptoms of Charcot-Marie-Tooth disease can vary widely from person to person. Some people may notice mild changes during childhood, while others may not experience clear symptoms until adulthood. In many cases, the condition develops slowly, making early warning signs easy to overlook or mistake for common issues such as poor coordination, muscle weakness, or normal differences in foot shape.

One of the key features of CMT is progressive weakness and muscle wasting, especially in the feet, lower legs, hands, and arms. Over time, this can affect walking ability, grip strength, and everyday activities. Changes in foot structure, frequent tripping, difficulty lifting the front of the foot, and reduced sensation are among the signs that may appear as the nerves become affected.

Understanding the possible symptoms of Charcot-Marie-Tooth disease is important because early recognition can make a meaningful difference in managing the condition. While there is currently no cure for CMT, treatments such as physical therapy, occupational therapy, supportive devices, and lifestyle adjustments can help maintain mobility and improve quality of life.

In this article, we will explore the 12 key signs of Charcot-Marie-Tooth disease in detail, including the symptoms people often notice first, how the condition affects the body, and when it may be helpful to speak with a healthcare professional. Continue reading to discover the important signs of CMT and learn more about what they may mean.

Table of Contents

What is Charcot-Marie-Tooth Disease?

Charcot-Marie-Tooth (CMT) disease is a group of inherited neurological disorders that primarily damage the peripheral nerves, which are the nerves located outside the brain and spinal cord. To understand better, it’s crucial to examine how this damage occurs and how CMT differs from other conditions that cause muscle weakness.

The disease is named after the three physicians, Jean-Martin Charcot, Pierre Marie, and Howard Henry Tooth, who first described it in 1886. As a progressive condition, the symptoms of CMT typically worsen over time, impacting both motor nerves, which control muscle movement, and sensory nerves, which transmit sensations like touch, pain, and temperature.

This dual impact on both motor and sensory functions distinguishes it from many other neuromuscular disorders. The severity and specific symptoms can vary widely among individuals, even within the same family, depending on the specific genetic mutation responsible for the condition.

The Effects of Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease affects the body by disrupting the normal function of peripheral nerves, which leads to impaired communication between the central nervous system and the limbs, muscles, and sensory organs.

More specifically, the genetic mutations responsible for CMT interfere with the production of proteins that are essential for the structure and function of either the nerve’s axon or its protective myelin sheath. The axon is the long, slender fiber of a nerve cell that transmits electrical impulses, while the myelin sheath is a fatty layer that insulates the axon, allowing for rapid and efficient signal transmission.

In some types of CMT (demyelinating types, like CMT1), the myelin sheath is damaged, causing nerve signals to slow down significantly or be lost altogether. This is akin to an electrical wire losing its insulation, leading to a weak and unreliable current. In other types (axonal types, like CMT2), the axon itself deteriorates, which reduces the strength of the nerve signal. This is like the wire itself being frayed or broken.

In both cases, the result is that the muscles do not receive clear or strong enough signals from the brain to contract properly, leading to progressive weakness and atrophy. Similarly, sensory signals from the hands and feet may be diminished or distorted on their way back to the brain, causing numbness, tingling, and a reduced ability to sense temperature or pain.

The Relationship Between Charcot-Marie-Tooth Disease and Muscular Dystrophy

Charcot-Marie-Tooth disease is primarily a neuropathy affecting the nerves, whereas Muscular Dystrophy is a myopathy directly affecting the muscles, although both conditions cause progressive muscle weakness.

To illustrate the key difference, one must understand the origin of the weakness in each disorder. In CMT, the muscles themselves are initially healthy, but they weaken and waste away (atrophy) because the nerves that supply them with electrical signals are damaged. The problem lies within the nervous system’s communication lines. The muscles are not receiving the necessary instructions to function, so they gradually deteriorate from disuse and lack of stimulation.

In contrast, Muscular Dystrophy (MD) is a group of genetic diseases where the primary defect is within the muscle fibers themselves. In MD, mutations in genes responsible for creating proteins needed to form healthy muscle cause the muscle cells to become weak and degenerate over time. The nerves that control these muscles are typically healthy and send proper signals, but the muscles are unable to respond correctly because of their intrinsic structural flaws. This fundamental distinction is critical for diagnosis and treatment.

While a patient with either condition might present with difficulty walking or climbing stairs, a neurologist can differentiate them through tests like nerve conduction studies, which would show abnormalities in a CMT patient but would likely be normal in an MD patient.

12 Key Signs of Charcot-Marie-Tooth Disease?

Foot Drop

This is often one of the earliest and most noticeable signs. It is characterized by the inability to lift the front part of the foot due to weakness in the tibialis anterior muscle. To compensate, individuals often adopt a steppage or high-stepping gait, lifting their knee higher than normal to avoid tripping over their toes. This can make walking on uneven surfaces particularly challenging and increases the risk of falls.

High Arches (Pes Cavus)

Many individuals with CMT develop abnormally high arches in their feet. This structural change occurs because of an imbalance in muscle strength; the smaller intrinsic muscles within the foot weaken, allowing the stronger, larger muscles of the lower leg to pull the foot into a high-arched position. Pes cavus can cause foot pain, calluses on the ball and heel of the foot, and difficulty fitting into standard shoes.

Hammertoes

This condition involves the toes bending or curling downward at the middle joint, resembling a hammer. Like high arches, hammertoes result from muscle imbalances in the foot. The weakened muscles are unable to hold the toes in a straight position, leading to this deformity. Hammertoes can cause pain, corns, and calluses where the toes rub against footwear.

Muscle Atrophy

As the disease progresses, the muscles in the lower legs, particularly below the knee, begin to waste away. This muscle loss can lead to a very thin appearance of the calves, often described as an inverted champagne bottle or stork leg shape, where the lower leg is noticeably thinner than the thigh. This atrophy is a direct result of the denervation of the peroneal and tibial muscles.

Frequent Ankle Sprains

Weakness in the muscles that stabilize the ankle joint leads to chronic instability. This makes the ankle more susceptible to rolling or twisting, resulting in frequent sprains. This instability, combined with sensory loss that affects proprioception (the sense of where one’s body is in space), makes walking treacherous and can contribute to falls.

Weak Hand Grip

Individuals with CMT often experience a progressive loss of strength in their hands. This makes everyday tasks that require a firm grip, such as opening jars, turning doorknobs, or carrying heavy objects, increasingly difficult. The weakness affects the intrinsic muscles of the hand as well as the larger muscles of the forearm that control finger flexion. This can impact a person’s independence and may require the use of adaptive tools.

Loss of Fine Motor Skills

The combination of muscle weakness and sensory loss in the fingers leads to a decline in fine motor coordination. Tasks that require precise hand movements, such as buttoning a shirt, zipping a jacket, writing with a pen, or using a keyboard, become challenging and clumsy. This loss of dexterity is often one of the most impactful aspects of the disease, affecting work, hobbies, and personal care routines. Handwriting may become messy and difficult to read as the muscles needed for controlled finger movements weaken.

Muscle Wasting in the Hands

Similar to the muscle atrophy seen in the lower legs, the muscles in the hands can also begin to waste away. This is often most visible in the fleshy area between the thumb and index finger (the first dorsal interosseous muscle) and can create a hollowed-out or “skeletal” appearance. The loss of these small, intrinsic hand muscles is a major contributor to the weakness in grip and the decline in fine motor skills. This visible sign is a clear indicator of the progression of the disease into the upper extremities.

Numbness or Tingling

Damage to sensory nerves often results in a reduced ability to feel sensations like touch, pain, and temperature, particularly in the hands and feet. This often presents as numbness, a “pins and needles” sensation (paresthesia), or a burning feeling. This sensory loss can be dangerous, as it increases the risk of injuries like cuts or burns going unnoticed, which can lead to infections, especially on the feet.

Balance Problems

Poor balance is a multifaceted problem in CMT, stemming from a combination of factors. Muscle weakness in the ankles and legs, foot deformities like pes cavus, and the loss of proprioception all contribute. Proprioception is the body’s ability to sense its position in space, and when the sensory nerves in the feet that provide this feedback are damaged, the brain receives inaccurate information. This makes it difficult to maintain balance, especially on uneven ground or in the dark, leading to an increased risk of falls.

Chronic Neuropathic Pain

While some individuals with CMT experience little to no pain, many suffer from chronic neuropathic pain. This pain is caused by the damaged nerves sending abnormal signals to the brain. It is often described as a burning, aching, or shooting pain in the limbs. Musculoskeletal pain from joint deformities and muscle strain due to altered gait mechanics can also be a significant issue.

Scoliosis

Although not as common as the limb-related symptoms, a curvature of the spine (scoliosis) can occur in some individuals with CMT, particularly those with an early onset of the disease. It is believed to be caused by weakness and imbalance in the muscles of the trunk that support the spine. In severe cases, scoliosis can affect breathing and may require bracing or surgical correction.

What Causes Charcot-Marie-Tooth Disease?

Charcot-Marie-Tooth disease is caused by inherited mutations in genes that are responsible for the normal structure and function of the peripheral nerves. To understand better, these genes produce specific proteins that are vital components of either the axon (the nerve fiber) or the myelin sheath (the protective insulation around the axon).

When a mutation occurs, the resulting protein is either faulty or not produced in sufficient quantities, leading to the breakdown and dysfunction of the peripheral nerves. Over 100 different genes have been identified as causing various types of CMT, which explains the wide variability in symptoms and severity seen among patients.

The inheritance patterns of these gene mutations also differ; they can be passed down in an autosomal dominant, autosomal recessive, or X-linked manner. This genetic foundation means that CMT is not caused by lifestyle factors, injury, or infection but is instead a condition that is passed down through families from one generation to the next.

Charcot-Marie-Tooth disease is always a genetic disorder, but it is not always inherited from a parent in a traceable way, because a small percentage of cases arise from a spontaneous new mutation. Specifically, in most instances, an individual with CMT has inherited a faulty gene from one or both parents. A detailed family history will often reveal other relatives with similar symptoms, even if they were never formally diagnosed.

This follows standard inheritance patterns (autosomal dominant, autosomal recessive, or X-linked). However, in some cases, a person may be the first in their family to have CMT. This occurs when a de novo or spontaneous mutation happens in the egg or sperm cell of a parent or very early in embryonic development.

In this scenario, the parent does not have the faulty gene and therefore does not have CMT, but their child does and can then pass the condition on to their own children. So, while the cause is always a gene mutation, the origin of that mutation is not always a direct line of inheritance from an affected parent. Therefore, the absence of a family history does not rule out a diagnosis of CMT.

Charcot-Marie-Tooth Disease Diagnosis

Charcot-Marie-Tooth disease is diagnosed using a multi-step process that combines a thorough physical examination, specialized nerve function tests, and definitive genetic testing. To begin, the diagnostic journey typically starts when a patient presents with classic symptoms like foot drop, high arches, or hand weakness.

A primary care physician will often refer the patient to a neurologist, a specialist in disorders of the nervous system. The neurologist integrates information from the patient’s personal and family medical history with findings from a detailed neurological exam. If CMT is suspected, the diagnosis is further investigated with electrodiagnostic tests that directly measure nerve and muscle function.

The final and most precise step is often a genetic blood test, which can identify the specific gene mutation causing the disease, confirming the diagnosis and classifying the exact type of CMT. This comprehensive approach ensures that other potential causes of neuropathy are ruled out and provides a clear picture of the patient’s condition.

Physical Examinations

The physical examinations performed to diagnose CMT are a comprehensive neurological assessment that evaluates muscle strength, reflexes, sensation, and physical characteristics of the limbs. More specifically, a neurologist conducts a series of tests to look for the classic signs of the disease.

The doctor will test the strength of various muscle groups in the hands, arms, feet, and legs. They will look for patterns of weakness that are characteristic of CMT, such as weakness in the muscles that lift the foot (dorsiflexion) or spread the fingers. The physician will also visually inspect for muscle wasting (atrophy), particularly in the lower legs (“stork leg” appearance) and hands.

Deep tendon reflexes, such as the knee-jerk reflex, are often reduced or absent in individuals with CMT. The neurologist will use a reflex hammer to tap on tendons at the ankles, knees, and elbows to check the response. An absent ankle reflex is a very common finding.

The patient’s ability to feel different sensations is tested. This can involve checking for responses to light touch, pinprick, vibration (using a tuning fork), and temperature in the hands and feet. A stocking-glove pattern of sensory loss, where sensation is diminished in the feet and hands, is a hallmark of peripheral neuropathy.

The neurologist will ask the patient to walk in order to observe their gait. The presence of a high-stepping or “steppage” gait is a strong indicator of foot drop. The doctor will also examine the feet for structural deformities like high arches (pes cavus) and hammertoes.

Diagnostic Tests to Confirm CMT

The three main diagnostic tests that confirm Charcot-Marie-Tooth disease are Nerve Conduction Studies (NCS), Electromyography (EMG), and genetic blood tests, which are used to measure nerve function, assess muscle activity, and identify the underlying gene mutation. To illustrate their roles:

Nerve Conduction Studies (NCS) is a crucial test for diagnosing CMT. It measures the speed and strength of electrical signals traveling through the peripheral nerves. During an NCS, small electrodes are placed on the skin over a nerve. One electrode stimulates the nerve with a mild electrical impulse, and other electrodes record the resulting electrical activity further down the nerve. In demyelinating types of CMT (like CMT1), the speed of the signal (conduction velocity) will be significantly slowed. In axonal types (like CMT2), the speed may be normal, but the strength of the signal (amplitude) will be reduced. These results not only help confirm a neuropathy but also help classify its type.

Electromyography (EMG) is often performed along with NCS. This test assesses the health of the muscles and the nerve cells that control them (motor neurons). A thin needle electrode is inserted into a muscle to record its electrical activity both at rest and during contraction. In CMT, the EMG can show evidence of active denervation (nerve damage) and chronic reinnervation (the body’s attempt to repair the damage), which are characteristic signs of a slowly progressive neuropathy.

Genetic testing is the definitive test for confirming a CMT diagnosis. A blood sample is taken, and the DNA is analyzed to look for mutations in the genes known to cause CMT. Genetic testing can identify the specific type and subtype of CMT (e.g., CMT1A due to a PMP22 duplication). A positive genetic test provides a conclusive diagnosis, can help predict the disease’s progression, and is essential for family planning and genetic counseling.

The Broader Considerations for Living with CMT

Living with Charcot-Marie-Tooth disease involves understanding its specific type, its long-term progression, how it differs from other neurological conditions, and the comprehensive management strategies available to maintain a high quality of life. Furthermore, navigating this journey requires a focus on a multidisciplinary care approach that addresses physical, occupational, and emotional well-being, as the condition affects each individual uniquely.

Different Types of Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease is not a single disorder but a group of inherited conditions, broadly categorized based on which part of the peripheral nerve is affected. The primary classifications are CMT1 and CMT2, which together account for the vast majority of cases. CMT1 is the most common form and is known as a demyelinating neuropathy.

In this type, the genetic mutations affect the production of proteins involved in the structure and function of the myelin sheath, the insulating layer that covers nerve fibers. This damage to the myelin slows down the conduction of nerve signals, leading to muscle weakness and sensory loss. Conversely, CMT2 is classified as an axonal neuropathy.

In these cases, the genetic defect directly impacts the axon, which is the nerve fiber itself. The axon degenerates, reducing the strength of the electrical signal transmitted to the muscles. Beyond these main categories, there are several rarer classifications. This comprehensive disease classification helps in understanding the underlying pathology.

CMT1 (Demyelinating) is the most prevalent type. It is characterized by a significant slowing of nerve conduction velocity (NCV) due to a faulty myelin sheath. Symptoms often appear in childhood or adolescence.

CMT2 (Axonal) is the second most common type. Here, the NCV is often normal or only slightly reduced, but the amplitude of the nerve signal is diminished due to axonal damage. The onset of symptoms is typically later than in CMT1.

Some individuals exhibit features of both demyelinating and axonal damage, placing them in intermediate CMT.

CMTX and CMT4 are rarer forms. CMTX is linked to a mutation on the X chromosome, affecting males more severely than females. CMT4 encompasses several subtypes of autosomal recessive demyelinating neuropathies, which are often more severe.

How does Charcot-Marie-Tooth Disease Progress Over Time?

The prognosis for an individual with Charcot-Marie-Tooth disease is highly variable, but the condition is almost always slowly progressive. Unlike some aggressive neurological disorders, the decline in function with CMT typically occurs over decades rather than months or years.

The rate of progression depends heavily on the specific genetic subtype of CMT, the age of onset, and individual factors. Symptoms usually begin in the feet and lower legs with issues like foot drop, high arches (pes cavus), and hammertoes.

As the disease progresses, this weakness and muscle atrophy can gradually ascend to affect the hands and forearms, leading to difficulty with fine motor skills such as buttoning shirts or writing. Sensory loss, including a reduced ability to feel touch, heat, and cold in the hands and feet, also worsens over time.

While the progression is lifelong, it is important to understand that CMT does not typically shorten life expectancy. The focus of care is not on a cure but on proactive disease management to mitigate symptoms and preserve function.

The progression can differ significantly even among family members who share the same genetic mutation. One person may require braces in their twenties, while another may only experience mild symptoms well into middle age. Over time, individuals may need to adopt assistive devices, such as ankle-foot orthoses (AFOs) to manage foot drop, canes for stability, or adaptive tools for daily tasks.

While the underlying nerve damage is progressive, the severity of symptoms like fatigue and pain can fluctuate day to day, influenced by activity levels, stress, and overall health. Managing these fluctuations is a key part of living with the condition.

The Difference Between Charcot-Marie-Tooth Disease and Multiple Sclerosis

A key aspect of comparative neurology is distinguishing between conditions with overlapping symptoms, and a common point of confusion is the difference between Charcot-Marie-Tooth disease and Multiple Sclerosis (MS).

Although both are neurological disorders that can cause muscle weakness and sensory problems, they affect entirely different parts of the nervous system. The fundamental distinction is that CMT is a disease of the Peripheral Nervous System (PNS), whereas MS is a disease of the Central Nervous System (CNS).

The CNS consists of the brain and spinal cord, acting as the body’s command center. The PNS is the vast network of nerves that branch out from the spinal cord to all other parts of the body, transmitting signals to and from the limbs and organs.

This core difference explains the distinct symptom profiles and disease pathways. In MS, the body’s immune system attacks the myelin sheath of nerves within the brain and spinal cord, leading to a wide range of potential symptoms, including vision problems, cognitive deficits, spasticity, and bladder dysfunction, alongside weakness and numbness. In contrast, CMT is caused by genetic mutations that disrupt the structure and function of the peripheral nerves.

Effective Treatments for Charcot-Marie-Tooth Disease

While there is currently no cure for Charcot-Marie-Tooth disease, there are numerous highly effective treatments and management strategies that significantly improve mobility, manage pain, and enhance overall quality of life. The answer to whether there is a treatment is no for a cure, but a definitive yes for managing the condition.

The cornerstone of disease management is a multidisciplinary approach that typically involves a team of healthcare professionals, including neurologists, physical therapists, occupational therapists, and orthotists. This comprehensive strategy is tailored to an individual’s specific symptoms and needs, focusing on maintaining independence and function for as long as possible.

The primary interventions are non-pharmacological and focus on physical support and rehabilitation. Physical therapy is crucial for developing a safe exercise program that maintains muscle strength without over-fatiguing the muscles. Stretching routines help prevent or reduce joint contractures that can result from muscle imbalance.

Occupational therapy helps individuals adapt to challenges in daily living by teaching new ways to perform tasks and recommending assistive devices for activities like dressing, cooking, and writing.

FAQs

1. What is the life expectancy of someone with CMT?

For most people, Charcot-Marie-Tooth disease does not significantly reduce life expectancy. CMT is generally a slowly progressive condition that mainly affects the peripheral nerves, muscles, and movement rather than vital organs. Many individuals with CMT live a normal lifespan, although the severity of symptoms can vary depending on the type of CMT and the level of disability it causes. With proper medical care, physical therapy, and supportive treatments, many people continue to maintain independence and a good quality of life.

2. Does Charcot-Marie-Tooth affect the brain?

No, CMT typically does not affect the brain. The condition mainly damages the peripheral nerves, which are the nerves outside the brain and spinal cord. These nerves control muscle movement and carry sensory information such as touch, temperature, and pain. Because the brain itself is not usually affected, people with CMT generally have normal thinking, memory, and intelligence.

3. What age does CMT start?

Charcot-Marie-Tooth disease can begin at any age, but symptoms often appear during childhood, adolescence, or early adulthood. Some people notice signs such as difficulty running, frequent tripping, weak ankles, or changes in foot shape early in life. Others may not recognize symptoms until later adulthood, especially if the condition progresses slowly.

4. What actress just died from Charcot-Marie-Tooth disease?

There is no widely confirmed report of a famous actress who recently died specifically from Charcot-Marie-Tooth disease. Although some public figures have shared their experiences with CMT, the condition itself is usually not considered a life-threatening disease. It is important to check reliable sources when hearing claims about celebrity health conditions.

5. How to stop CMT from progressing?

Currently, there is no cure that can completely stop or reverse CMT. However, many strategies can help slow functional decline and manage symptoms. Regular physical therapy, strength and flexibility exercises, maintaining a healthy weight, using supportive footwear or braces, and monitoring nerve and muscle health can help preserve mobility and independence.

6. Does CMT get worse as you get older?

CMT is usually a progressive condition, meaning symptoms may gradually increase over time. However, progression is often slow and varies greatly between individuals. Some people experience only mild weakness, while others may develop more noticeable problems with walking, balance, or hand function as they age.

7. Is CMT like Parkinson’s?

CMT and Parkinson’s disease are different conditions. Parkinson’s affects the brain and involves problems with movement control, often causing tremors, stiffness, and slowed movement. CMT affects peripheral nerves and mainly causes muscle weakness, loss of sensation, foot deformities, and difficulty with coordination.

8. Does walking help CMT?

Yes, walking can be beneficial for many people with CMT when done safely and at an appropriate level. Regular movement may help maintain muscle strength, flexibility, circulation, and overall mobility. However, exercise plans should be adjusted based on symptoms, balance ability, and guidance from healthcare professionals to avoid overexertion.

Conclusion

Charcot-Marie-Tooth disease is a complex inherited nerve disorder that can affect movement, sensation, and daily activities in different ways. While symptoms such as muscle weakness, foot changes, balance difficulties, and reduced sensation may gradually develop, many people with CMT continue to live active and fulfilling lives with proper management.

Understanding the key signs of CMT can help individuals recognize possible symptoms earlier and seek appropriate medical support. Although there is currently no cure, treatments such as physical therapy, mobility support, and lifestyle adjustments can make a meaningful difference in maintaining independence and improving quality of life.

If you or someone you know experiences signs associated with Charcot-Marie-Tooth disease, learning more about the condition and discussing concerns with a healthcare professional can be an important step toward better care and long-term management.

References

Disclaimer This article is intended for informational and educational purposes only. We are not medical professionals, and this content does not replace professional medical advice, diagnosis, or treatment. The goal is to provide accurate, evidence-based information to raise awareness of causes. If you are experiencing persistent, severe, or concerning symptoms, you should seek guidance from a qualified healthcare provider. Read the full Disclaimer here →